dr. brahmer on the impower150 trial in nsclc
Published 6 years ago • 116 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:55
dr. langer on the impower150 trial in nsclc
-
1:05
dr. reck on the rationale of the impower150 trial in nsclc
-
1:29
dr. brahmer on managing immune-related aes in lung cancer
-
1:25
dr. brahmer on chemoimmunotherapy in patients with nsclc
-
0:31
copy of dr. brahmer on the role of immunotherapy in metastatic nsclc
-
1:54
dr. brahmer on impact of checkmate-057 in nsclc
-
1:31
dr. brahmer on the role of immunotherapy in metastatic nsclc
-
2:11
dr. kim discusses data from the impower150 trial in nonsquamous nsclc
-
1:15
dr. brahmer on immunotherapy beyond pd-1/l1 in nsclc
-
1:39
dr. sequist on implications of the impower150 trial in advanced nonsquamous nsclc
-
6:51
impower150: implications for the treatment of nsclc
-
1:23
dr. brahmer on biomarkers for immune response in nsclc
-
1:32
dr. brahmer on the benefit of immunotherapy in metastatic nsclc
-
1:41
dr. brahmer discusses second-line pembrolizumab in nsclc
-
3:28
advanced-stage nondriver nsclc: impower150 trial
-
2:19
dr brahmer on the investigation of flx475 in nsclc
-
0:58
dr. julie r. brahmer on immunotherapy development in lung cancer
-
5:15
metastatic nsclc: a look at the impower150 trial
-
1:14
dr. brahmer on immunotherapy in stage iv nsclc